Archive for December, 2008

FDA Consumer - Combination drug treatment approved for ulcers - Food and Drug Administration approves use of Biaxin, or clarithromycin, and Prilosec, or omeprazole, to treat…

Wednesday, December 31st, 2008

The first antibiotic treatment for eradicating Helicobacter pylori, the bacteria associated with active duodenal ulcers, has been approved by FDA.
The treatment involves taking two previously approved drugs: Biaxin (clarithromycin) and Prilosec (omeprazole). It was approved April 18.
Biaxin, manufactured by Abbott Laboratories, is an antibiotic for various mild to moderate infections. Prilosec, manufactured by Astra Merck, is a proton pump inhibitor that helps heal u…

Hospital Materials Management - Abbott Laboratories, Abbott Park, Ill., in late April sent cases of hospital, pharmaceutical and nutritional products valued at $2.1 million to AmeriCares, a…

Monday, December 29th, 2008

Abbott Laboratories, Abbott Park, Ill., in late April sent cases of hospital, pharmaceutical and nutritional products valued at $2.1 million to AmeriCares, a not-for-profit humanitarian aid organization, to aid victims of the war in Iraq. Anothe…

Daily Herald (Arlington Heights, IL) - Lake County Briefs.(Business)

Friday, December 26th, 2008

Big Foot reports smaller profit LONG GROVE - Big Foot Financial Corp. announced first-quarter earnings ended Sept. 30 of $157,000, or 10 cents per share, down from $181,000, or 9 cents per share the same quarter a year ago. Net interest income declined to $1.5 million from $1.6 million in 1999.

Related Results

Biaxin FilmtabTeva Provides Generic Biaxin XL UpdateFDA OKs Abbott…

Chain Drug Review - Abbott approval

Wednesday, December 24th, 2008

Abbott Laboratories has received FDA approval for a community acquired pneumonia (CAP) indication for Biaxin XL (clarithromycin extended-release tablets). The product is a once-daily version of Biaxin and is indicated for treating mild to moderate CAP.

Related Results

Biaxin FilmtabTeva Provides Generic Biaxin XL UpdateFDA OKs Abbott's seven-day Biaxin treatmentAndrx Receives Final Approval fo…

Internal Medicine News - Pneumonia Treatment

Friday, December 19th, 2008

Biaxin XL (clarithromycin extended-release tablets) has a new 7-day indication for the treatment of mild to moderate community-acquired pneumonia. The once-daily formulation is indicated for the treatment of community-acquired pneumonia caused by Haemophilus influenzae, H. parainfluenzae, Morax…

Business Wire - Teva Initiates Phase III Study to Confirm Increased Efficacy of Higher Dose of Glatiramer Acetate for the Treatment of Relapsing-Remitting Multiple Sclerosis;…

Tuesday, December 16th, 2008

The Centers for Disease Control and Prevention (CDC) has released guidelines on antimicrobial agents for the treatment and postexposure prophylaxis of pertussis. The full report was published in the December 9, 2005, issue of Morbidity…

Business Wire - Acusphere Presents at Controlled Release Society

Saturday, December 13th, 2008

-Intravenous Delivery of Clopidogrel Enabled-
WATERTOWN, Mass. — Acusphere, Inc. (NASDAQ:ACUS) announced that Rajeev A. Jain, Ph.D., Manager of Formulations Support and Pharmaceutics for Acusphere, presented a poster on the “Preparation of an Emulsion Formulation of Clopidogrel for Intravenous Administration” at the 34th An…

FDA Consumer - Keeping up with drug safety information

Wednesday, December 10th, 2008

The Food and Drug Administration approves a drug for marketing after determining that the drug’s benefits outweigh the risks for the intended user. But even with a rigorous evaluation process, some safety …

Generic Zithromax Azithromycin Antibiotics Medication Information

Friday, December 5th, 2008

What is Generic Zithromax azithromycin?
Generic Zithromax Azithromycin is in a group of drugs called macrolide antibiotics. Zithromax Azithromycin fights bacteria in the body.
Generic Zithromax Azithromycin is used to treat many different types of infections caused by bacteria, such as respiratory infections, skin infections, ear infections, and sexually transmitted diseases.
Generic Zithromax Azithromycin may also be used for purpos…

Business Wire - Andrx Corporation Reports Financial Results for 2006 First Quarter

Monday, December 1st, 2008

FORT LAUDERDALE, Fla. — Andrx Corporation (Nasdaq:ADRX) (”Andrx” or the “Company”) today announced its financial results for the three months and year ended December 31, 2005 (the “2005 Quarter” and the “2005 Year”, respectively), which are discussed more extensively in Andrx’s annual report on Form 10-K for the year ended December 31, 2005 being filed today with the U.S. Securities and Exchange Commission (SEC). Andrx’s 2005 Form 10-K is …